Fusobacterium nucleatum Acts as a Pro-carcinogenic Bacterium in Colorectal Cancer: From Association to Causality.
TLDR
In this paper, the authors summarized the biological characteristics of Fusobacterium nucleatum and the epidemiological associations between F. nucleatum, and highlighted the mechanisms by which F.ucleatum participates in CRC progression, metastasis, and chemoresistance by affecting cancer cells or regulating the tumor microenvironment.Abstract:
Colorectal cancer (CRC) is a common cancer worldwide with complex etiology. Fusobacterium nucleatum (F. nucleatum), an oral symbiotic bacterium, has been linked with CRC in the past decade. A series of gut microbiota studies show that CRC patients carry a high abundance of F. nucleatum in the tumor tissue and fecal, and etiological studies have clarified the role of F. nucleatum as a pro-carcinogenic bacterium in various stages of CRC. In this review, we summarize the biological characteristics of F. nucleatum and the epidemiological associations between F. nucleatum and CRC, and then highlight the mechanisms by which F. nucleatum participates in CRC progression, metastasis, and chemoresistance by affecting cancer cells or regulating the tumor microenvironment (TME). We also discuss the research gap in this field and give our perspective for future studies. These findings will pave the way for manipulating gut F. nucleatum to deal with CRC in the future.read more
Citations
More filters
Journal ArticleDOI
Oral microbiota in human systematic diseases
TL;DR: In this article , the authors discussed emerging and exciting evidence of complex and important connections between the oral microbes and multiple human systemic diseases, and the possible contribution of the oral microorganisms to systemic diseases.
Journal ArticleDOI
Integrated metagenomic and metabolomic analysis reveals distinct gut-microbiome-derived phenotypes in early-onset colorectal cancer
Cheng Kong,Lei Liang,Guang Liu,Lutao Du,Yongzhi Yang,Jianqiang Liu,Debing Shi,Xinxiang Li,Yan-yan Ma +8 more
TL;DR: The predictive model based on metagenomic, metabolomic and KO gene markers achieved a powerful classification performance for distinguishing EO-CRC from controls, suggesting that altered microbiome–metabolome interplay helps explain the pathogenesis of EO.CRC.
Journal ArticleDOI
Alterations in the Gut Microbiota and Their Metabolites in Colorectal Cancer: Recent Progress and Future Prospects
TL;DR: Gut microbiota and their metabolites influence the progression and causation of CRC, and the association analysis of metabolomics and gut microbiome will provide novel strategies for the prevention, diagnosis, and therapy of CRC.
Journal ArticleDOI
Dysbiosis of skin microbiome and gut microbiome in melanoma progression
Chahrazed Mekadim,Helena Kupcova Skalnikova,Jana Čížková,Veronika Cizkova,A Palanová,D. Horák,Jakub Mrázek +6 more
TL;DR: In this article , the authors examined associations between dysbiosis in the skin and gut microbiome and the melanoma growth using MeLiM porcine model of melanoma progression and spontaneous regression.
Journal ArticleDOI
Dysbiosis of skin microbiome and gut microbiome in melanoma progression
Chahrazed Mekadim,Helena Kupcova Skalnikova,Jana Čížková,Veronika Cizkova,A Palanová,D. Horák,Jakub Mrázek +6 more
TL;DR: In this article , the authors examined associations between dysbiosis in the skin and gut microbiome and the melanoma growth using MeLiM porcine model of melanoma progression and spontaneous regression.
References
More filters
Journal ArticleDOI
Patients with colorectal cancer have identical strains of Fusobacterium nucleatum in their colorectal cancer and oral cavity.
Yasuhiko Komiya,Yumi Shimomura,Takuma Higurashi,Yutaka Sugi,Jun Arimoto,Shotaro Umezawa,Shiori Uchiyama,Mitsuharu Matsumoto,Atsushi Nakajima +8 more
TL;DR: This study examined whether identical strains of F .
Journal ArticleDOI
Cancer Inflammation and Cytokines
TL;DR: Tumor-associated macrophages and TANs are both integrated in cancer-related inflammation and an ever better understanding of their functions can be useful to tailor the use of anticancer therapeutic approaches and patient follow-up.
Journal ArticleDOI
Could gut microbiota serve as prognostic biomarker associated with colorectal cancer patients' survival? A pilot study on relevant mechanism.
Zhiliang Wei,Shougen Cao,Shanglong Liu,Zengwu Yao,Teng Sun,Yi Li,Jiante Li,Dongfeng Zhang,Yanbing Zhou +8 more
TL;DR: 16S rRNA gene sequencing approach found that Fusobacterium nucleatum and Bacteroides fragilis were more abundant in worse prognosis groups, while Faecalibacterium prausnitzii displayed higher abundance in survival group, and dysbiosis might worsen the patients' prognosis by up-regulating gut inflammation level.
Journal ArticleDOI
Fusobacterium nucleatum promotes chemoresistance to 5-fluorouracil by upregulation of BIRC3 expression in colorectal cancer
TL;DR: BIRC3 was the most upregulated gene induced by Fn infection via the TLR4/NF-κB pathway in CRC cells; Fn infection reduced the chemosensitivity of CRC cells to 5-Fu through upregulation of BIRC3 in vitro and in vivo.
Journal ArticleDOI
The mutual interplay of gut microbiota, diet and human disease
TL;DR: Interventions based on microbiome studies, that is faecal microbiota transplantation, probiotics and prebiotics, are discussed to introduce the concept that correcting gut dysbiosis can ameliorate disease symptoms, thus offering a new approach towards disease treatment.